Dabur India Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹3,764Cr
- +10.5% YoY
- +23.9% QoQ
- Net profit
- ₹586Cr
- +15.4% YoY
- +61.9% QoQ
- Margin
- 20%
- 0 pp YoY
- +5 pp QoQ
Guidance rank: #6 of 7 in Personal Products
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
1 of 4 strong
The short version
Dabur India Limited projects double-digit consolidated revenue growth for FY27, driven by both India and international businesses. Dabur expects a 14%-15% PAT growth at the consolidated level in coming quarters, contingent on double-digit top-line growth (Page 10).
From Dabur India's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Dabur India Limited projects double-digit consolidated revenue growth for FY27, driven by both India and international businesses.
- India FMCG business expects around 9.5% revenue growth with approximately 5% volume growth.
- Hair oil business targets double-digit value growth, supported by 8% volume growth.
- Volume growth overall is expected to be under pressure due to inflation; revenue growth will be more driven by price increases.
- The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues.
- Rural demand remains resilient and growing ahead of urban, supporting future sales.
- Innovation and premiumization strategies, including new launches like Vatika’s Bio-Infusions and D2C initiatives, support growth.
2 more points from Dabur India's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Dabur India said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Dabur India Limited has allocated approximately INR 400-500 crores for greenfield capex projects, including investments in Tamil Nadu, which will consume cash.
- There is an earmarked INR 500 crores for strategic acquisitions, especially targeting mid to large scale companies or to gain a foothold in Direct-to-Consumer (D2C) businesses through Dabur Ventures.
- The company aims to acquire 1 or 2 sizable companies within the next 3 years as part of its strategic acquisition plan.
- Routine capex for expansion is ongoing to support business growth.
2 more points from Dabur India's call on capex
Create a free account to keep reading this call
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Dabur India said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Dabur India said on order book & pipeline — free account, 30 seconds.
Dabur India — Quarterly revenue & net profit
Dabur India Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 3,764 | 3,405 | +10.5% | 3,038 | +23.9% |
| Operating profit (EBITDA) | 741 | 667 | +11.1% | 461 | +60.7% |
| Operating margin | 20% | 20% | 0 pp | 15% | +5 pp |
| Profit before tax | 756 | 663 | +14% | 474 | +59.5% |
| Net profit (PAT) | 586 | 508 | +15.4% | 362 | +61.9% |
| EPS (₹) | 3.33 | 2.90 | +14.8% | 2.08 | +60.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹3.6K Cr, net profit ₹499 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dabur India's management said in earlier quarters
Others in Personal Products this season
- Bajaj Consumer (Q1 FY27)
Recent quarters saw exponential growth: 20% YoY in FY26 and 28% YoY in Q1 FY27, partly due to prior price corrections and strategic actions (Nishita Shanklesha…
- Colgate-Palmoliv (Q1 FY27)
Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium…
- Emami (Q1 FY27)
Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Key concall takeaways from Emami's Q1 FY27 earnings call…
- Godrej Consumer (Q1 FY27)
The company reported strong broad-based revenue growth of 19% YoY and volume growth of 9%, reflecting healthy demand. Key concall takeaways from Godrej…
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- EmamiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Dabur India and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Dabur India Q1 FY27 results?
Dabur India Limited projects double-digit consolidated revenue growth for FY27, driven by both India and international businesses. Dabur expects a 14%-15% PAT growth at the consolidated level in coming quarters, contingent on double-digit top-line growth (Page 10).
What is Dabur India share price analysis?
Dabur India currently shows a below-average growth signal. The stock trades at a P/E of 35.8 with a market cap of ₹71,047 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dabur India planning capital expenditure?
Dabur India Limited has allocated approximately INR 400-500 crores for greenfield capex projects, including investments in Tamil Nadu, which will consume cash.
Keep Dabur India on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
